about
Addressing current challenges in cancer immunotherapy with mathematical and computational modelling.Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook.Optogenetic Immunomodulation: Shedding Light on Antitumor Immunity.Local delivery of checkpoints antibodies.The current state of therapeutic and T cell-based vaccines against human papillomaviruses.Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination.Immune modulation by dendritic-cell-based cancer vaccines.Engineering challenges for brain tumor immunotherapy.Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment.Bioengineering of Artificial Antigen Presenting Cells and Lymphoid Organs.Artificial human antigen-presenting cells are superior to dendritic cells at inducing cytotoxic T-cell responses.Nanomaterials for the Capture and Therapeutic Targeting of Circulating Tumor Cells.Rethinking cancer nanotheranostics.Promoting immunology: The future is here.Recent advances in microfluidic technologies for cell-to-cell interaction studies.Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models.Designing biomaterials with immunomodulatory properties for tissue engineering and regenerative medicine.Current status and future directions of cancer immunotherapy.Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway.Biotinylated Bilirubin Nanoparticles as a Tumor Microenvironment-Responsive Drug Delivery System for Targeted Cancer Therapy.Immuno-Oncology: Emerging Targets and Combination TherapiesNew opportunities for nanoparticles in cancer immunotherapyIntegrating Immunology and Microfluidics for Single Immune Cell Analysis
P2860
Q33861540-F2B2BE34-2751-448A-9534-94D2898BDF03Q38677432-D15F6771-FF8A-438D-8074-354FEC5C8710Q38815767-B60F906C-A507-4692-A9F5-991EB1EC5BC2Q38817657-4B6D1097-9981-4FEC-A928-A7A7D9DA1BD5Q39033576-F27F0D91-8868-43E8-870B-751F6BB32B99Q39049093-DC658038-B28F-47F3-A94C-6446C92CF65AQ39147683-B06EC77A-429F-4DE2-9112-4DCB3BEA8036Q39381281-4FD5B319-CB19-4B8E-A830-A96F49867B8CQ39388967-4B8446A1-69E1-488D-B735-7BE6AFCDA1CDQ40044791-05DE3E3B-5B6E-4F51-8571-A0628D2B4563Q40140002-368C58F7-DABE-4B98-9CB1-0F505971A5BFQ42339249-B034EE30-F93D-4865-BA9B-CC97C81A4453Q42640884-B02749F4-11AF-4A9F-9285-580F976D089BQ46790654-9CBE0D1F-26CB-4289-AF76-57D511E4FD8CQ49978957-A199EDDB-75BE-4697-9BC7-E6743098159BQ50423295-2E54B08E-2795-4C01-AFBD-F46C6BB34156Q53064170-D37E6AF8-FD05-4E6E-9D87-95D5CE0D247BQ55070491-E9052557-17AB-491C-82F0-D08F059C0EEDQ55294642-817F0EA0-358E-4593-A10F-33909BFF9BFCQ55318784-E1772F35-61E0-4799-A45C-3CBD292B30DCQ56889817-925899D2-89E1-4776-BC52-0F6F9CE2757CQ57069049-C3DCDAB2-C76D-4957-B95C-F2CA967B9228Q59136363-30012602-1292-4041-BCC3-BADFFB5A9CB9
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Engineering opportunities in cancer immunotherapy
@ast
Engineering opportunities in cancer immunotherapy
@en
Engineering opportunities in cancer immunotherapy
@nl
type
label
Engineering opportunities in cancer immunotherapy
@ast
Engineering opportunities in cancer immunotherapy
@en
Engineering opportunities in cancer immunotherapy
@nl
prefLabel
Engineering opportunities in cancer immunotherapy
@ast
Engineering opportunities in cancer immunotherapy
@en
Engineering opportunities in cancer immunotherapy
@nl
P2860
P356
P1476
Engineering opportunities in cancer immunotherapy
@en
P2093
Laura Jeanbart
Melody A Swartz
P2860
P304
14467-14472
P356
10.1073/PNAS.1508516112
P407
P577
2015-11-23T00:00:00Z